Brownstein Zippora, Goldfarb Abraham, Levi Haya, Frydman Moshe, Avraham Karen B
Department of Human Molecular Genetics and Biochemistry, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Arch Otolaryngol Head Neck Surg. 2006 Apr;132(4):416-24. doi: 10.1001/archotol.132.4.416.
To perform chromosomal mapping and clinical analysis of hereditary otosclerosis linked to the fourth locus for otosclerosis (OTSC4) in an Israeli family.
Pedigree study.
A genetics of hearing loss research laboratory, a clinical genetics laboratory, a center for speech and hearing, and an otolaryngology department at a university and medical centers in Israel.
An Israeli family of which 24 members were ascertained and a pedigree was constructed; 12 members had otosclerosis.
Confirmation of otosclerosis by surgery (3 subjects) and by audiologic evaluation, medical history, and family history (9 subjects), and whole-genome scanning to identify the chromosomal region of the mutant locus.
Chromosomal location of the otosclerosis locus.
Linkage to the 16q21-23.2 interval was identified and confirmed with a logarithm of odds (LOD) score of 3.97 at theta = 0. The new locus for otosclerosis was designated OTSC4. The OTSC4 interval of 9 to 10 megabase includes several genes involved in the immune system and bone homeostasis that may be good candidates for genes otosclerosis.
The elucidation of the OTSC4 gene may disclose the etiology of the disorder, and the functional and structural analysis of the protein may open new options for diagnosis, treatment, and prevention of otosclerosis.
对一个以色列家庭中与耳硬化症第四位点(OTSC4)相关的遗传性耳硬化症进行染色体定位和临床分析。
系谱研究。
以色列一所大学和医疗中心的听力损失遗传学研究实验室、临床遗传学实验室、言语和听力中心以及耳鼻喉科。
确定了一个有24名成员的以色列家庭并构建了系谱;其中12名成员患有耳硬化症。
通过手术(3名受试者)以及听力评估、病史和家族史(9名受试者)确诊耳硬化症,并进行全基因组扫描以确定突变位点的染色体区域。
耳硬化症位点的染色体定位。
确定与16q21 - 23.2区间存在连锁关系,并在θ = 0时对数优势(LOD)分数为3.97得到确认。耳硬化症的新位点被命名为OTSC4。9至10兆碱基的OTSC4区间包含几个参与免疫系统和骨稳态的基因,这些基因可能是耳硬化症相关基因的良好候选者。
OTSC4基因的阐明可能揭示该疾病的病因,对该蛋白的功能和结构分析可能为耳硬化症的诊断、治疗和预防开辟新的途径。